Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a debilitating autosomal dominant, neurodegenerative disease with a fatal prognosis. Classical features include motor disturbances, dementia and psychiatric problems but are not restricted to this triad as patients often experience other abnormalities such as unintended weight loss, the exact cause of which is unknown. We studied the body composition of 25 premanifest HD and compared it to 25 control subjects using a dual energy x-ray absorptiometer (DEXA) scan. Like the R6/2 transgenic mouse model, we identified significantly lower bone mineral density z-scores in premanifest individuals, that was not related to any difference in testosterone, cortisol, leptin or Vitamin D levels. These results identify an early gene-related change that occurs in HD which not only could lead to a potential biomarker for the disease, but given it is also seen in other manifest neurodegenerative diseases, could also reveal a common disease related process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Even if no obvious evidence for the relationship between osteoporosis and HD is available, bone mineral density is significantly lower in pre-HD carriers than in healthy controls.299”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [299]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,347
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735 · cited 1×
“[32] One of leptin’s functions is to affect bone mass [33] [34] by inducing bone loss, [35] yet again we found no significant difference in leptin levels between study groups.”
BackgroundLeptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311 · cited 1×
“[32] One of leptin’s functions is to affect bone mass [33] [34] by inducing bone loss, [35] yet again we found no significant difference in leptin levels between study groups.”
BackgroundRelationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
Snell, R. G., MacMillan, J. C., Cheadle, J. P., Fenton, I., Lazarou, L. P., Davies, P., MacDonald, M. E., Gusella, J. F., Harper, P. S., & Shaw, D. J. (1993) · Nature Genetics · doi:10.1038/ng0893-393 · Cited by 709
Widespread expression of Huntington's disease gene (IT15) protein product
Sharp, A. H., Loev, S. J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Wagster, M. V., Kotzuk, J. A., Steiner, J. P., Lo, A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90345-3 · Cited by 513
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice
van der Burg, J. M. M., Winqvist, A., Aziz, N. A., Maat–Schieman, M. L. C., Roos, R. A. C., Bates, G. P., Brundin, P., Björkqvist, M., & Wierup, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.006 · Cited by 118
Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
Wang, R., Ross, C. A., Cai, H., Cong, W., Daimon, C. M., Carlson, O. D., Egan, J. M., Siddiqui, S., Maudsley, S. R., & Martin, B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00231 · Cited by 83
Zhou, Y. G., Gao, Y., Xu, C., Shen, H., Tian, Q., & Deng, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19196-2 · Cited by 81
Systemic manifestation and contribution of peripheral tissues to Huntington’s disease pathogenesis
Chuang, C.-L., & Demontis, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101358 · Cited by 70
A Metabolic Study of Huntington’s Disease
Nambron, R., Silajdžić, E., Kalliolia, E., Ottolenghi, C., Hindmarsh, P. C., Hill, N. R., Costelloe, S. J., Martin, N. G., Positano, V., Watt, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146480 · Cited by 64
Hölter, S. M., Stromberg, M., Kovalenko, M. V., Garrett, L., Glasl, L., Lopez, E., Guide, J. R., Götz, A. A., Hans, W., Becker, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080923 · Cited by 48
Body composition and bone mineral density in Huntington's disease
de Miranda, R. C., Lorenzo, N. D., Andréoli, A., Romano, L., Santis, G. L. D., Gualtieri, P., & LORENZO, A. D. (2018) · Nutrition · doi:10.1016/j.nut.2018.08.005 · Cited by 38
Schurman, C. A., Burton, J. B., Rose, J., Ellerby, L., Alliston, T. N., & Schilling, B. (2023) · Journal of Bone Metabolism · doi:10.11005/jbm.2023.30.1.1 · Cited by 35
Wells, R. G., Neilson, L. E., McHill, A. W., & Hiller, A. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00406-z · Cited by 38
Zielonka, D., Witkowski, G., Puch, E. A., Leśniczak-Staszak, M., Mazur-Michałek, I., Isalan, M., & Mielcarek, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00079 · Cited by 21
Chel, V. G. M., Ooms, M. E., van der Bent, J., Veldkamp, F., Roos, R. A. C., Achterberg, W. P., & Lips, P. T. A. M. (2013) · Dermato-Endocrinology · doi:10.4161/derm.26135 · Cited by 19
Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting
Nielsen, S. M. B., Vinther‐Jensen, T., Nielsen, J. E., Nørremølle, A., Hasholt, L., Hjermind, L. E., & Josefsen, K. E. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.018 · Cited by 20
Characteristics, Pathophysiology and Clinical Management of Weight Loss in Huntington’s Disease
Aziz, N. A., & Roos, R. A. C. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.22 · Cited by 17
Vitamin D and Hyperkinetic Movement Disorders: A Systematic Review
Homann, C. N., Ivanic, G. M., Homann, B., & Purkart, T. U. (2020) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.74 · Cited by 13
Molnar, M. F., Maszlag-Török, R., Vágvölgyi-Sümegi, E., Vécsei, L., Klivènyi, P., & Szalárdy, L. (2016) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2017-017 · Cited by 13
Accidental Falls in Patients with Hyperkinetic Movement Disorders: A Systematic Review
Homann, C. N., Homann, B., Ivanic, G. M., & Urbanic-Purkart, T. (2022) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.709 · Cited by 11
Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions
Burtscher, J., Strasser, B., Pepe, G., Burtscher, M., Kopp, M., Pardo, A. D., Maglione, V., & Khamoui, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094696 · Cited by 8
Farina, G., & Crescioli, C. (2025) · Molecules · doi:10.3390/molecules30183823 · Cited by 5
Beyond the brain: Polyglutamine disease pathology outside the nervous system
Rausch, J. P., Bradley, B., Demontis, F., & Todi, S. V. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107539 · Cited by 4
Polyglutamine disease in peripheral tissues
Barwell, T., & Seroude, L. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad138 · Cited by 4
Khalil, H. W. (2012) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 2
Huntington's Disease and Other Choreas
Salman, H., Wild, E. J., & Tabrizi, S. J. (2017) · Wiley eBooks · doi:10.1002/9781118661895.ch21 · Cited by 3
Sex Differences in Huntington’s Disease: Considerations for Clinical Care and Research Trials
Rocha, N. P., Teixeira, A. L., & Furr-Stimming, E. E. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_19 · Cited by 1
Treatment of vitamin D deficiency in Dutch nursing home residents
Chel, V. G. M. (2014) · Pure Amsterdam UMC
Gene–Environment Interactions in Huntington’s Disease
Bichell, T. J., Uhouse, M. A., Bradley, E. M., & Bowman, A. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00017-0
Nateghi, B., Bouali, M. L., Bouredji, Z., Argaw, A., Jayash, S. N., Farquharson, C., Frenette, J., & Hébert, S. S. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251387208
Qin, H., Hao, M., Wang, Z., Zhang, J., Xie, M., Diao, Y., Hu, X., Rong, H., & Zhu, T. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05275-z
Metadata
- Authors
- Goodman, A. O. G., & Barker, R. A.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Barker, Roger A
- Venue
- PLoS Currents
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-28
- Volume
- 3
- Pages
- RRN1214
- ISSN
- 2157-3999 (ISSN-L)
- PMC
- PMC3047010
- OpenAlex
- W2119313826
- Cited by
- 28
- References
- 40
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- PLoS Currents (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- Huntington's disease, premanifest Huntington's disease, body composition, bone mineral density, bone loss, neurodegeneration, biomarkers, testosterone, cortisol, leptin, vitamin D, weight loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
